Literature DB >> 28164142

Importance of Substrate-Coupled Proton Antiport by the Vesicular Monoamine Transporter in the Actions of Amphetamines in Drosophila Brain.

Takato Hiranita1, Zachary Freyberg2.   

Abstract

Entities:  

Year:  2016        PMID： 28164142      PMCID： PMC5287573          DOI： 10.4172/2329-6488.1000e136

Source DB:  PubMed          Journal:  J Alcohol Drug Depend        ISSN： 2329-6488


× No keyword cloud information.
  30 in total

1.  3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.

Authors:  John H Anneken; Mariana Angoa-Pérez; Donald M Kuhn
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

2.  Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.

Authors:  A C Meyer; D B Horton; N M Neugebauer; T E Wooters; J R Nickell; L P Dwoskin; M T Bardo
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

3.  meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.

Authors:  David B Horton; Kiran B Siripurapu; Seth D Norrholm; John P Culver; Marhaba Hojahmat; Joshua S Beckmann; Steven B Harrod; Agripina G Deaciuc; Michael T Bardo; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2010-12-21       Impact factor: 4.030

4.  Suppression of methamphetamine-seeking behavior by nicotinic agonists.

Authors:  Takato Hiranita; Yoko Nawata; Katsuya Sakimura; Kusnandar Anggadiredja; Tsuneyuki Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

5.  Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.

Authors:  Linda Garcés-Ramírez; Jennifer L Green; Takato Hiranita; Theresa A Kopajtic; Maddalena Mereu; Alexandra M Thomas; Christophe Mesangeau; Sanju Narayanan; Christopher R McCurdy; Jonathan L Katz; Gianluigi Tanda
Journal:  Biol Psychiatry       Date:  2010-10-15       Impact factor: 13.382

6.  Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.

Authors:  Emilia Marchei; Magí Farré; Ricardo Pardo; Oscar Garcia-Algar; Manuela Pellegrini; Roberta Pacifici; Simona Pichini
Journal:  Clin Chem       Date:  2010-02-18       Impact factor: 8.327

7.  Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Seth D Norrholm; Peter A Crooks
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

8.  Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects.

Authors:  S T Sweeney; K Broadie; J Keane; H Niemann; C J O'Kane
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

9.  Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.

Authors:  Justin R Nickell; Sairam Krishnamurthy; Seth Norrholm; Gabriela Deaciuc; Kiran B Siripurapu; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2009-10-23       Impact factor: 4.030

10.  Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts.

Authors:  J Knoth; M Zallakian; D Njus
Journal:  Biochemistry       Date:  1981-11-10       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.